Kaletra and T-cell type acute leukaemia - from FDA reports
There is no T-cell type acute leukaemia reported by people who take Kaletra yet. This review analyzes which people have T-cell type acute leukaemia with Kaletra. It is created by eHealthMe based on reports from FDA, and is updated regularly.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 19, 2017
No report is found.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have T-cell type acute leukaemia when taking Kaletra?
- Check symptoms - is t-cell type acute leukaemia caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- write a review - share your experience related to the study
- More tools...
Expand the study to include all drugs with the same ingredientsT-cell type acute leukaemia and drugs with ingredients of lopinavir; ritonavir.
Expand the study to include reports from both FDA and eHealthMeT-cell type acute leukaemia and Kaletra from FDA and eHealthMe reports
Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. (latest outcomes from Kaletra 17,412 users)
T-cell Type Acute Leukaemia
T-cell type acute leukaemia (a form of cancer of the white blood cells) has been reported by people with crohn's disease, rheumatoid arthritis, breast cancer, multiple myeloma, acute myeloid leukaemia (latest reports from 628 T-cell type acute leukaemia patients).